India Readies 72-Officer Force To Check Imported Drugs
This article was originally published in PharmAsia News
India's chief regulator says his office is establishing a 72-officer work force to check the quality of imported drugs. Some of the inspectors and technical associates are to be sent to other countries to inspect drugs, a reversal of what has been the usual practice. The traveling inspectors are to begin moving in the first quarter of next year. Surinder Singh, the drug controller general of India, told a conference the DCGI also plans to cooperate with the country's port authorities to address the problem. (Click here for more
You may also be interested in...
With a pipeline of over 35 ANDAs, India's Caplin Steriles plans to launch five generic injectables through a strategic partnership with Xellia Pharma in the US market. Out of the five ANDAs, one has been approved and is ready for launch.
Sanofi has received formal approval from the European Commission for its insulin aspart biosimilar.
Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy.